Jumpcode Genomics
Founded in 2016, Jumpcode Genomics aims to improve the understanding of human biology and the contribution to disease. The company’s proprietary CRISPRclean technology utilizes the CRISPR/Cas system to deplete unwanted nucleic acid molecules from sequencing libraries. The process fits seamlessly within standard next generation sequencing workflows and works with most commercially available library preparation solutions.
Content by Jumpcode Genomics
|3 min read
New Technology Addresses the ‘Needle in the Haystack’ Problem of Molecular Biology
Patented CRISPRclean™ technology is a foundational tool that improves the performance of next-generation sequencing and other molecular workflows by increasing sensitivity, reducing costs, and enabling novel discoveryPage 1 of 1




